| Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. [Journal Article]
Lancet 2000 Apr 1; 355(9210):1131-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
|
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. [Journal Article]
J Natl Cancer Inst 2000 Nov 15; 92(22):1823-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Porter K, Babiker A, Bhaskaran K, et al.
Determinants of survival following HIV-1 seroconversion after the introduction of HAART. [Journal Article]
Lancet 2003 Oct 18; 362(9392):1267-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Dorrucci M, Pezzotti P, Phillips AN, et al.
Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study. [Journal Article]
AIDS 1997 Mar 15; 11(4):461-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Pezzotti P, Dorrucci M, Donisi A, et al.
[Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)] [Journal Article]
Epidemiol Prev 2003 Nov-Dec; 27(6):348-55.
Abstract | Full Citation | Find Related Articles |
| Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe. [Letter]
Lancet 2000 Apr 1; 355(9210):1158-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Rezza G
Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study. [Journal Article, Multicenter Study]
J Acquir Immune Defic Syndr Hum Retrovirol 1998.:S13-6.
Abstract | Full Citation | Find Related Articles |
| Detels R, Muñoz A, McFarlane G, et al.
Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. [Journal Article]
JAMA 1998 Nov 4; 280(17):1497-503.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
|
Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. [Journal Article]
HIV Med 2000 Oct; 1(4):224-31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
